Merck & Co., Inc. (MRK)
NYSE
Healthcare
Drug Manufacturers - General
$123.43
▲ +2.19%
Market Cap
$304.85B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.20
52-Wk Range
76.66-130.29
CEO
Robert Davis
Country
US
Currency
USD
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of v…
Open full interactive analysis & DCF →